Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Inclusion Criteria: * Healthy females between, and including, 9 and 45 years of age at the time of enrolment * Be able to provide legal identification for the sake of recruitment * Be able to understand and sign informed consent form prior to enrollment and for subjects aged 9-17 years, they and their legal guardian(s) are supposed to understand and sign informed consent form together * Subjects who the investigator believes that they can and will comply with the protocol requirements * Subject must be not pregnant at the enrollment and agree to use adequate contraceptive precautions within 7 months or don't have pregnancy plan Exclusion Criteria: * Fever or axillary temperature\> 37.0℃ before vaccination * Previous vaccination against HPV * Planned administration/administration of investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days preceding first dose of vaccine * Planned to take part in other clinical research within 7 months after participating this study or have taken part in other clinical research within 3 months before participating this study * Abnormal laboratory tests parameters(except the part the clinician diagnosed as non clinical significance) * Administration of any whole blood, plasma or immunoglobulins products within 3 months preceding first vaccination * Interval between administration of the study vaccination and any attenuated live vaccine less than 14 days, and other vaccines less than 10 days * His…